U.S. Physical Therapy (USPH) Scheduled to Post Quarterly Earnings on Tuesday

U.S. Physical Therapy (NYSE:USPH - Get Free Report) will be releasing its earnings data after the market closes on Tuesday, May 7th. Analysts expect U.S. Physical Therapy to post earnings of $0.58 per share for the quarter. Parties that wish to register for the company's conference call can do so using this link.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, February 28th. The company reported $0.59 EPS for the quarter, beating analysts' consensus estimates of $0.57 by $0.02. U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. The company had revenue of $154.80 million during the quarter, compared to the consensus estimate of $150.24 million. During the same quarter last year, the firm posted $0.58 EPS. The company's quarterly revenue was up 9.6% on a year-over-year basis. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Stock Performance

NYSE:USPH traded down $0.47 during mid-day trading on Tuesday, hitting $101.51. The stock had a trading volume of 48,044 shares, compared to its average volume of 69,288. The company's 50 day simple moving average is $105.03 and its 200 day simple moving average is $95.64. The stock has a market cap of $1.53 billion, a price-to-earnings ratio of 75.54, a PEG ratio of 4.77 and a beta of 1.39. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.28 and a current ratio of 2.28. U.S. Physical Therapy has a twelve month low of $78.08 and a twelve month high of $124.11.

U.S. Physical Therapy Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 5th. Investors of record on Tuesday, March 12th were issued a dividend of $0.44 per share. The ex-dividend date of this dividend was Monday, March 11th. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.43. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.73%. U.S. Physical Therapy's payout ratio is presently 130.37%.

Analysts Set New Price Targets

A number of research firms have commented on USPH. StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Monday, March 18th. Barrington Research boosted their price objective on U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an "outperform" rating in a report on Friday, March 1st. Finally, JPMorgan Chase & Co. increased their target price on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an "overweight" rating in a research note on Wednesday, March 13th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $125.67.

Insider Buying and Selling at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 2,629 shares of the firm's stock in a transaction on Monday, March 4th. The stock was sold at an average price of $104.39, for a total value of $274,441.31. Following the transaction, the chief operating officer now owns 6,902 shares in the company, valued at $720,499.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, COO Graham D. Reeve sold 2,629 shares of the company's stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $104.39, for a total transaction of $274,441.31. Following the completion of the sale, the chief operating officer now owns 6,902 shares of the company's stock, valued at approximately $720,499.78. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Carey P. Hendrickson sold 1,800 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total transaction of $193,104.00. Following the completion of the transaction, the chief financial officer now directly owns 21,186 shares in the company, valued at $2,272,834.08. The disclosure for this sale can be found here. Insiders sold 10,829 shares of company stock valued at $1,141,535 in the last quarter. Company insiders own 1.80% of the company's stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.